Meet the Team
Claudia Alejandra McDonald Bøen, Ph.D.
Chief Executive Officer
Claudia A. McDonald Bøen is leading the research team at Arctic Pharma AS. She has experience in both academia and industry. Claudia has been involved in designing cancer diagnostic tools, drug development and commercialization of products for scientific use prior to joining Arctic Pharma.
Claudia received her Master of Science degree from San Francisco State University in California, USA. Her master studies focused on developing and applying methods for analyzing the glycoproteome in breast cancer cells. That same year she cofounded a proteomics software company, Proteome Solutions. Claudia graduated with a Ph.D. in biological chemistry from the University of Michigan in Ann Arbor, USA. Her doctoral work focused on studying the mechanism of flavin-dependent enzymes by kinetics and spectroscopy.
Anja R. Oldenburg, Ph.D.
Senior Scientist in Cellular Biology
Anja has a Ph.D. from the Max Planck Institute for Experimental Medicine in Göttingen, Germany and has held post-doctoral and researcher positions in different areas of molecular and cellular biology at the University of Oslo and Oslo University Hospital. In addition, she has experience in therapeutic antibody development from her work at the biotechnology company Affitech.
At Arctic Pharma, Anja plays an important role in the preclinical stages of drug development. She works on identifying and evaluating Arctic Pharma’s current and new potential drug targets. She is also leading the design and development of critical cellular assays used to evaluate drug candidates’ effects on cancers cells and their ability to proliferate and metastasize.
Steffi Lundvall, Ph.D.
Lead Scientist in Biochemistry
Steffi holds a Ph.D. degree rooted both in structural biology and organic chemistry. During her studies, she focused on drug development against Mycobacterium tuberculosis enzymes. This work involved high-throughput compound screening, structure-activity relationship studies and co-crystallization of inhibitor compounds with the target enzymes as well as structure determination. Her broad background enables her to work at the interface of biology and organic synthetic chemistry.
Steffi uses her extensive knowledge in techniques used for studying the interaction of small molecule inhibitors (drug leads) with their biological targets at Arctic Pharma. She plays a major role in the development and executions of enzymatic assays in Arctic Pharma’s biochemistry team.
Steffi enjoys cooking in the kitchen as much as cooking in the laboratory and is always up for a cooking challenge.
Kathrin Hnida, Ph.D.
Scientist in Biochemistry
Kathrin obtained her Ph.D. from the University of Oslo, Center for Immune Regulation. Her focus was on biochemical and biophysical characterization of enzyme-antibody interactions. Furthermore, she holds a M.Sc. in chemistry, with specialization in biochemistry. This broad educational background and experience in immunology, organic chemistry, biochemistry and biophysics makes her a valuable team-member of Arctic Pharma.
Kathrin plays an important role in Arctic Pharma’s biochemistry team. She is responsible for designing and optimizing assays that help Arctic Pharma evaluate the properties of drug candidates. Kathrin also uses inhibitor-enzyme x-ray crystallography complexes to identify specific interactions of Arctic Pharma’s drugs on their target enzymes to improve drug candidates.
Northern Germany was not cold enough for her, so Kathrin moved further up north. She looks forward to fairytale Norwegian winters to use her spare energy on winter sports.
Karl J. Bonney, Ph.D.
Senior Scientist in Medicinal Chemistry
Karl obtained his Ph.D. in organic chemistry from Imperial College London. He then carried out postdoctoral research within the area of organometallic chemistry and catalysis at both the ETH Zurich and the RWTH Aachen. Most recently he has gained experience within the pharmaceutical industry in Scandinavia, working on the development of drugs for the treatment of CNS disorders, as well as developing compounds to help to tackle multi-drug resistant bacterial infections.
Elahe Jafari, Ph.D.
Scientist in Medicinal Chemistry
Elahe graduated with a Ph.D. in organic chemistry from the University of Oslo. Her doctoral work focused on synthesis of heterocycles as Quorum sensing inhibitors. Prior to joining Arctic Pharma, Elahe has been involved in synthesizing natural products and enzyme inhibitors.
Elahe is a part of Arctic Pharma's medicinal chemistry team. She, together with Karl, work on designing, synthesizing and analyzing new drug compounds that are made in house.
In her free times, she likes to run and swim, and she can also be found attending sport events whenever possible!
Director of Mental Stimulation
Trimethylxanthine is a vital component of the Arctic Pharma team. They help guide other team members to a good morning every day in the office. And they also contribute immensely to group meetings making sure that everyone follows all results and problems discussed.
Specialist in Anti-Depressant Biology
Theobromine is another important member of the Arctic Pharma team. Whether it is to overcome a difficult day in the lab or celebrate an important milestone reached, they are always on board to help lift the team spirit. Although Theobromine likes to work alone, they are also found to collaborate with glucose and lactose.